Immatics (IMTX) Interest Expenses (2019 - 2025)
Immatics (IMTX) reported Interest Expenses of -$258417.7 for Q4 2025, down 115.7% on a YoY basis from $1.6 million in Q4 2024, and up 23.51% sequentially from -$337856.9 in Q3 2025.
Immatics (IMTX) Interest Expenses (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Interest Expenses data on file, last reported at -$258417.7 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 115.7% year-over-year to -$258417.7; the trailing twelve-month figure through Dec 2025 stood at -$40.4 million (down 205.09% YoY), and the FY2025 full-year result was -$41.4 million, down 2797.37% from the prior year.
- Interest Expenses climbed to -$258417.7 in Q4 2025, from -$337856.9 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.6 million in Q4 2024 to a low of -$25.8 million in Q2 2025.
- A 5-year average of -$3.3 million and a median of -$746476.8 in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 526.5% in 2022 and slumped 7749.43% in 2025, its largest moves.
- Tracing IMTX's Interest Expenses over 5 years: stood at -$372934.5 in 2021, then surged by 526.5% to $1.6 million in 2022, then slumped by 295.76% to -$3.1 million in 2023, then soared by 152.85% to $1.6 million in 2024, then tumbled by 115.7% to -$258417.7 in 2025.
- Business Quant data shows IMTX's Interest Expenses at -$258417.7 in Q4 2025, -$337856.9 in Q3 2025, and -$25.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | -258,417.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -258,417.66 |
| Dec 31, 2025 | -258,417.66 |
| Sep 30, 2025 | -337,856.92 |
| Sep 30, 2025 | -337,856.92 |
| Jun 30, 2025 | -25.78 Mn |
| Jun 30, 2025 | -25.78 Mn |
| Mar 31, 2025 | -14.03 Mn |
| Mar 31, 2025 | -14.03 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -328,450.71 |
| Jun 30, 2024 | -328,450.71 |
| Mar 31, 2024 | -735,466.92 |
| Mar 31, 2024 | -735,466.92 |
| Dec 31, 2023 | -3.11 Mn |
| Dec 31, 2023 | -3.11 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Sep 30, 2023 | -1.71 Mn |